Concord Medical Services (CCM) Stock Price, News & Analysis

Company Overview

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Key Stats

• Today's Range: $4.50 to $4.96
• 50-Day Range: $4.35 to $6.45
• 52-Week Range: $3.82 to $26.70
• Volume: 12,864 shs
• Average Volume: 13,566 shs
• Market Capitalization: $20.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Concord Medical Services Stock Analysis - MarketRank™

Concord Medical Services scored higher than 13% of companies evaluated by MarketBeat, and ranked 894th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Concord Medical Services.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

Concord Medical Services has a P/B Ratio of 0.08. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.16% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently increased by 225.00%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Concord Medical Services does not currently pay a dividend.

Dividend Growth

Concord Medical Services does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.16% of the float of Concord Medical Services has been sold short.

Short Interest Ratio / Days to Cover

Concord Medical Services has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Concord Medical Services has recently increased by 225.00%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 1.1 / 5
• News Sentiment: -0.11

News Sentiment

Concord Medical Services has a news sentiment score of -0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Concord Medical Services this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Concord Medical Services insiders have not sold or bought any company stock.

Percentage Held by Insiders

46.50% of the stock of Concord Medical Services is held by insiders. A high percentage of insider ownership can be a sign of company health.

CCM Stock Analysis - Frequently Asked Questions

How have CCM shares performed this year?

Concord Medical Services' stock was trading at $5.38 at the start of the year. Since then, CCM stock has decreased by 12.2% and is now trading at $4.7250.
View the best growth stocks for 2025 here.

How were Concord Medical Services' earnings last quarter?

Concord Medical Services Holdings Limited (NYSE:CCM) announced its earnings results on Wednesday, August, 24th. The company reported ($0.60) earnings per share for the quarter, missing analysts' consensus estimates of $2.10 by $2.70. The business earned $18.93 million during the quarter.

When did Concord Medical Services' stock split?

Shares of Concord Medical Services reverse split on Tuesday, July 30th 2024. The 1-10 reverse split was announced on Tuesday, July 30th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 30th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Concord Medical Services?

Shares of CCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Concord Medical Services own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Concord Medical Services investors own include M&T Bank (MTB), The Carlyle Group (CG), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD), Catalyst Biosciences (CBIO) and Chevron (CVX).

Company Calendar

• Last Earnings: 8/24/2016
• Today: 1/21/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Offices & clinics of medical doctors
• Sub-Industry: Healthcare
• Current Symbol: NYSE:CCM
• CUSIP: N/A
• CIK: 1472072
• Web: www.concordmedical.com
• Phone: 861059036688
• Fax: 86-10-5957-5252
• Employees: 970
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.15
• Current Ratio: 0.47
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: $471.70 million
• Price / Sales: 0.04
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $56.67 per share
• Price / Book: 0.08

Miscellaneous

• Outstanding Shares: 4,342,000
• Free Float: 2,323,000
• Market Cap: $20.52 million
• Optionable: Not Optionable
• Beta: -0.37